Trinity Biotech plc Furnishes 2023 Annual Report
Ticker: TRIB · Form: 6-K · Filed: Sep 5, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Sep 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, filing
TL;DR
Trinity Biotech dropped its 2023 annual report, check it for the latest financials.
AI Summary
Trinity Biotech plc filed a Form 6-K on September 5, 2024, to furnish its 2023 Annual Report as Exhibit 99.1. The report covers the company's performance and financial status for the fiscal year ending December 31, 2023. Trinity Biotech plc is an Irish company specializing in in vitro and in vivo diagnostic substances.
Why It Matters
This filing provides investors with the company's audited financial results and operational overview for the previous fiscal year, crucial for assessing its current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of an annual report, not indicating new material events or significant changes.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 2023 (date) — Fiscal Year End
- September 5, 2024 (date) — Filing Date
- Exhibit 99.1 (document) — Annual Report
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose is to furnish Trinity Biotech plc's 2023 Annual Report as Exhibit 99.1.
When was this Form 6-K filed?
This Form 6-K was filed on September 5, 2024.
What period does the furnished Annual Report cover?
The furnished Annual Report covers the fiscal year ending December 31, 2023.
What is Trinity Biotech plc's Standard Industrial Classification code?
Trinity Biotech plc's Standard Industrial Classification code is 2835, for In Vitro & In Vivo Diagnostic Substances.
Where is Trinity Biotech plc's principal executive office located?
Trinity Biotech plc's principal executive office is located at IDA Business Park, Bray, County Wicklow, Ireland.
Filing Stats: 162 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-09-05 10:52:57
Filing Documents
- zk2431993.htm (6-K) — 11KB
- exhibit_99-1.htm (EX-99.1) — 5128KB
- 0001178913-24-002977.txt ( ) — 5141KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: September 5, 2024 4